BCPC Stock Overview
Develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
BCPC passed our risk checks.
Community Narratives
Narratives bring a range of perspectives from our community.
Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion
Balchem Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$168.63 |
52 Week High | US$186.03 |
52 Week Low | US$110.74 |
Beta | 0.65 |
11 Month Change | 3.04% |
3 Month Change | 11.33% |
1 Year Change | 27.48% |
33 Year Change | 20.91% |
5 Year Change | 61.54% |
Change since IPO | 67,296.47% |
Recent News & Updates
Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today
Aug 27Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon
Aug 13Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184
Jul 31Recent updates
Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today
Aug 27Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon
Aug 13Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184
Jul 31Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Jun 29Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable
Jun 15Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jun 10Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
May 26Balchem: A Tale Of Two Businesses
May 10Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark
Dec 19Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Nov 20Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19The Returns At Balchem (NASDAQ:BCPC) Aren't Growing
Sep 09A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 22Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital
May 28Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 12We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Jan 11Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
Dec 29Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate
Nov 29Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Sep 20Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly
Sep 05Balchem to acquire Cardinal Associates or Bergstrom Nutrition
Aug 30Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?
Aug 22Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?
Aug 08Balchem Q2 2022 Earnings Preview
Jul 28Balchem: On The M&A Road Again
Jun 28Balchem: A New Growth Stage Is Just Beginning
Jun 02Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement
May 30Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price
May 18Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?
May 02Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?
Mar 28Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Feb 26Balchem (NASDAQ:BCPC) Could Easily Take On More Debt
Dec 23Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Nov 18Shareholder Returns
BCPC | US Chemicals | US Market | |
---|---|---|---|
7D | -4.7% | -4.7% | -4.4% |
1Y | 27.5% | 5.8% | 19.1% |
Return vs Industry: BCPC exceeded the US Chemicals industry which returned 5.8% over the past year.
Return vs Market: BCPC exceeded the US Market which returned 19.1% over the past year.
Price Volatility
BCPC volatility | |
---|---|
BCPC Average Weekly Movement | 3.7% |
Chemicals Industry Average Movement | 6.0% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 14.9% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BCPC has not had significant price volatility in the past 3 months.
Volatility Over Time: BCPC's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1967 | 1,290 | Ted Harris | www.balchem.com |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Balchem Corporation Fundamentals Summary
BCPC fundamental statistics | |
---|---|
Market cap | US$5.47b |
Earnings (TTM) | US$116.78m |
Revenue (TTM) | US$932.39m |
46.8x
P/E Ratio5.9x
P/S RatioIs BCPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BCPC income statement (TTM) | |
---|---|
Revenue | US$932.39m |
Cost of Revenue | US$616.34m |
Gross Profit | US$316.05m |
Other Expenses | US$199.27m |
Earnings | US$116.78m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 3.60 |
Gross Margin | 33.90% |
Net Profit Margin | 12.52% |
Debt/Equity Ratio | 24.0% |
How did BCPC perform over the long term?
See historical performance and comparison